Exelon downgraded to Neutral from Buy at ISI Group ISI Group downgraded Execlon to Neutral and cut its price target to $33 from $40. The analyst downgraded shares due to reasonable valuation and lack of visibility into the short-medium term power market.
Exelon upgraded to Outperform from Market Perform at Wells Fargo Wells Fargo upgraded Exelon to Outperform citing an attractive risk/reward ahead of likely reforms in the capacity market. Wells expects reforms to positively impact the value of ExGenís 19 GW nuclear fleet. It raised its price target range for shares to $43-$44 from $41-$42.